Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

LH stock hub

Labcorp Holdings Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.8B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

In the news

Latest news · LH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.9

P25 12.3P50 18.4P75 33.1

Trailing P/E22.5

P25 14.9P50 23.2P75 38.5

ROE11

P25 -105.6P50 -46.5P75 -3.1

ROIC8.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

276

Groups with data

Currency

USD

Showing 276 of 276 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000920148
Company name	Labcorp Holdings Inc.
Country	United States
Country code	US
Cusip	504922105
Employees	71,000
Employees Change	1,000%
Employees Change Percent	1.43
Enterprise value	$27.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Diagnostics & Research
Isin	US5049221055
Last refreshed	2026-05-10
Market cap	$20.8B
Market cap category	Large-Cap
Price	$254
Price currency	USD
Rev Per Employee	199,214.08x
Sector	Healthcare
Sic	8071
Symbol	LH
Website	https://www.labcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.52%
EV Earnings	28.84x
EV Sales Forward	1.78x
EV/EBIT	17.41x
EV/EBITDA	12.05x
EV/FCF	19.62x
EV/Sales	1.92x
FCF yield	6.64%
Forward P/E	13.89x
P/B ratio	2.4x
P/E ratio	22.52x
P/S ratio	1.47x
PE Ratio10 Y	21.93x
PE Ratio3 Y	31.56x
PE Ratio5 Y	24.01x
PEG ratio	1.62x
PS Forward	1.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.03%
EBITDA Margin	15.93%
FCF margin	9.78%
Gross margin	28.83%
Gross Profit	$4.1B
Gross Profit Growth	10.97%
Gross Profit Growth Q	6.94%
Gross Profit Growth3 Y	5.46%
Gross Profit Growth5 Y	-6.88%
Net Income	$941.5M
Net Income Growth	28.83%
Net Income Growth Q	30.55%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	-2%
Net Income Growth5 Y	-18.65%
Pretax Margin	8.14%
Profit Margin	6.66%
Profit Per Employee	$13,261
Profitable Years	28
ROA	5.31
Roa5y	5.62
ROCE	9.48
ROE	11.05
Roe5y	11.24
ROIC	8.6
Roic5y	9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.59%
Cagr15y	8.02%
Cagr1y	4.46%
Cagr20y	8.77%
Cagr3y	11.08%
Cagr5y	2.22%
Div CAGR10	14.87%
Div CAGR3	0%
Div CAGR5	31.95%
EPS Growth	30.21
EPS Growth Q	32.94
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	0.64
EPS Growth5 Y	-15.94
FCF Growth	20.14%
FCF Growth3 Y	7.24%
FCF Growth5 Y	-12.63%
OCF Growth	10.98%
OCF Growth Q	935.14%
OCF Growth10 Y	4.24%
OCF Growth3 Y	6.23%
OCF Growth5 Y	-10.1%
Revenue Growth	7.34x
Revenue Growth Q	5.76x
Revenue Growth Quarters	12x
Revenue Growth Years	3x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	-1.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.77
Assets	$19.1B
Cash	$981.1M
Current Assets	$4.6B
Current Liabilities	$2.6B
Debt	$7.3B
Debt EBITDA	$2.85
Debt Equity	$0.83
Debt FCF	$5.27
Equity	$8.7B
Interest Coverage	6.99
Liabilities	$10.3B
Long Term Assets	$14.5B
Long Term Liabilities	$7.7B
Net Cash	$-6.3B
Net Cash By Market Cap	$-30.3
Net Debt EBITDA	$2.8
Net Debt Equity	$0.72
Net Debt FCF	$4.56
Tangible Book Value	$-1.9B
Tangible Book Value Per Share	$-22.63
WACC	7.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	20.42
Net Working Capital	$1.6B
Quick ratio	1.3
Working Capital	$1.9B
Working Capital Turnover	$7.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$2.88
Dividend Years	5
Dividend Yield	1.13%
Ex Div Date	2026-05-29
Last Dividend	$0.72
Payout Frequency	Quarterly
Payout Ratio	25.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	149.76%
1Y total return	4.45%
200-day SMA	268.9
3Y total return	37.08%
50-day SMA	267.3
50-day SMA vs 200-day SMA	50under200
5Y total return	11.61%
All Time High	317.2
All Time High Change	-19.88%
All Time High Date	2021-12-31
All Time Low	2.81
All Time Low Change	8,933.77%
All Time Low Date	1998-08-31
ATR	7.27
Beta	0.88
Beta1y	0.34
Beta2y	0.35
Ch YTD	1.29
High	260
High52	293.7
High52 Date	2025-10-21
High52ch	-13.48%
Low	252.7
Low52	239.7
Low52 Date	2025-05-15
Low52ch	6.03%
Ma50ch	-4.94%
Price vs 200-day SMA	-5.48%
RSI	37.71
RSI Monthly	50.82
RSI Weekly	42.78
Sharpe ratio	0.13x
Sortino ratio	0.43
Total Return	2.14%
Tr YTD	1.55
Tr15y	218.1%
Tr1m	-5.59%
Tr1w	-0.67%
Tr3m	-8.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	5
Analyst Price Target Top	$311
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$4.11
Earnings EPS Estimate Growth	7.03
Earnings Revenue Estimate	3,507,406,800x
Earnings Revenue Estimate Growth	4.86x
Operating Income	$1.6B
Operating Income Growth	36.64
Operating Income Growth Q	16.49
Operating Income Growth3 Y	1.73
Operating Income Growth5 Y	-16.43
Operating margin	11.03
Price target	$311
Price Target Change	$22.51
Price Target Change Top	$22.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,596,940%
Float Percent	99.51%
Net Borrowing	750,000,000
Shares Insiders	0.4%
Shares Institutions	103.83%
Shares Out	82,000,000
Shares Qo Q	-0.36%
Shares Yo Y	-1.01%
Short Float	3.97%
Short Ratio	5.73
Short Shares	3.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.3B
Average Volume	745,203.9x
Bv Per Share	106.1
CAPEX	$-429.5M
Ch10y	104.5
Ch15y	160.4
Ch1m	-5.59
Ch1w	-0.67
Ch1y	3.34
Ch20y	340.1
Ch3m	-8.33
Ch3y	13.52
Ch5y	-8.64
Ch6m	0.55
Change	-1.52%
Change From Open	-1.59
Close	258.1
Days Gap	0.07
Depreciation Amortization	693,100,000
Dollar Volume	147,715,636
Earnings Date	2026-04-30
Earnings Time	bmo
EBIT	$1.6B
EBITDA	$2.3B
EPS	$11.29
F Score	5
FCF	$1.4B
FCF EV Yield	5.1x
FCF Per Share	$16.88
Financing CF	-36,800,000
Fiscal Year End	December
Founded	1,971
Goodwill	6,955,200,000
Graham Number	164.11037
Graham Upside	-35.42
Income Tax	$209.3M
Investing CF	-1,180,100,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2002-05-13
Last Split Type	Forward
Last10k Filing Date	2026-02-24
Lynch Fair Value	$56.43
Lynch Upside	-77.79
Ma150	267.4
Ma150ch	-4.96%
Ma20	262.6
Ma20ch	-3.24%
Net CF	611,700,000
Next Earnings Date	2026-07-23
Open	258.2
Optionable	Yes
P FCF Ratio	15.06
P OCF Ratio	11.49
Payment Date	2026-06-11
Position In Range	20.03
Ppne	3,065,500,000
Price Date	2026-05-08
Price EBITDA	$9.25
Relative Volume	0.78x
Revenue	14,144,200,000x
SBC By Revenue	0.88x
Share Based Comp	124,700,000
Tax By Revenue	1.48x
Tax Rate	18.17%
Tr20y	437.64%
Tr6m	1.08%
Us State	North Carolina
Volume	581,283
Z Score	3.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$2.88 annual per share

Payout ratio

+25.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+32.0%

0 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-05-29

Performance

LH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+103.8%

Float: +99.5% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.7

Neutral momentum band

Price vs 200-day MA

-5.5%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LH stock rating?

Labcorp Holdings Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LH analysis?

The full report lives at /stocks/LH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LH?

The latest report frames LH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.